Leadership Overview
Cynosure has 10 executives leading key functions including strategy, finance, technology, legal, operations, and sales.
Driven by innovation, Cynosure develops and manufactures energy-based aesthetic and medical treatment systems, enhancing offerings for practitioners and providing advanced treatments to patients worldwide.
Driven by innovation, Cynosure develops and manufactures energy-based aesthetic and medical treatment systems, enhancing offerings for practitioners and providing advanced treatments to patients worldwide.
Leadership Roles at Cynosure
Cyriacus Njoku - Chief Executive Officer & President
Cyriacus Njoku, the Chief Executive Officer & President at Cynosure, directs the company's overall strategic vision and operational execution. Njoku guides the development and manufacturing of energy-based aesthetic and medical treatment systems, ensuring alignment with market demands for hair removal, skin revitalization, scar reduction, gynecological health, and body contouring. This leadership role involves fostering innovation across all departments, from research and development to global sales and distribution. By overseeing the company's trajectory, Cyriacus Njoku ensures Cynosure remains at the forefront of the aesthetic and medical technology sector, driving growth and expanding its worldwide reach. The focus remains on empowering practitioners and physicians with cutting-edge solutions that benefit patients.
Timothy Gehlmann - Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc
Timothy Gehlmann, the Chief Executive Officer & President, Hoya Photonics Inc & of Hoya Photonics Inc at Cynosure, spearheads the strategic direction and operational management of Hoya Photonics. Gehlmann oversees the innovation and production of advanced photonics technologies, critical for various high-tech applications. This executive's responsibilities include driving market expansion and ensuring technological leadership within the photonics industry. By managing key business units and fostering cross-functional collaboration, Timothy Gehlmann ensures that Hoya Photonics contributes significantly to Cynosure's broader technological capabilities and market presence. The leadership ensures the delivery of cutting-edge solutions to a global clientele.
Gail Fajembola - Managing Director & Chief Executive Officer
Gail Fajembola, the Managing Director & Chief Executive Officer at Cynosure, leads the strategic initiatives and overall business performance. Fajembola directs the company's operations, focusing on enhancing its diverse range of energy-based aesthetic and medical treatment systems. This leadership position involves overseeing market penetration and ensuring the delivery of innovative solutions for hair removal, skin revitalization, and body contouring. By guiding the executive team and fostering a culture of excellence, Gail Fajembola drives the company's mission to empower practitioners and improve patient outcomes globally. The executive's focus is on sustainable growth and maintaining Cynosure's position as a market leader.
Robert Howe - Chief Financial Officer
Robert Howe, the Chief Financial Officer at Cynosure, directs the company's financial strategy and fiscal operations. Howe oversees all aspects of financial planning, reporting, and investment, ensuring the economic health and sustainable growth of the organization. This role involves managing capital allocation, optimizing financial performance, and providing critical insights to support strategic decision-making across the development and manufacturing of aesthetic and medical treatment systems. By maintaining robust financial controls and driving fiscal discipline, Robert Howe ensures Cynosure can continue to invest in innovation and expand its global market presence, supporting practitioners and patients worldwide.
Baker Baker - Executive Vice President & Chief Financial Officer
Baker Baker, the Executive Vice President & Chief Financial Officer at Cynosure, collaborates with the Chief Financial Officer to manage the company's financial architecture. Baker Baker oversees critical financial functions, including budgeting, forecasting, and financial analysis, supporting the strategic direction of energy-based aesthetic and medical treatment systems. This executive's responsibilities extend to ensuring financial compliance and optimizing resource allocation to drive innovation and market expansion. By providing strategic financial guidance, Baker Baker contributes to the company's ability to deliver cutting-edge solutions to practitioners and physicians globally, reinforcing Cynosure's commitment to patient care and technological advancement.
Scott Karten - President, Areavice of Sales (East)
Scott Karten, the President, Areavice of Sales (East) at Cynosure, leads sales initiatives and market development across the eastern territories. Karten directs the sales teams in expanding the reach of Cynosure's energy-based aesthetic and medical treatment systems, focusing on building strong relationships with practitioners and physicians. This executive's responsibilities include driving revenue growth, implementing effective sales strategies, and ensuring customer satisfaction within the region. By championing the company's innovative offerings for hair removal, skin revitalization, and body contouring, Scott Karten plays a crucial part in enhancing Cynosure's market presence and supporting the delivery of advanced patient treatments.
Christopher Aronson - President, North America
Christopher Aronson, the President, North America at Cynosure, spearheads the company's strategic growth and market leadership across the North American region. Aronson directs all commercial activities, focusing on expanding the adoption of Cynosure's diverse portfolio of energy-based aesthetic and medical treatment systems. This executive's purview includes driving sales performance, cultivating key partnerships with practitioners and physicians, and ensuring exceptional customer engagement. By overseeing regional operations, Christopher Aronson ensures that Cynosure's innovative solutions for hair removal, skin revitalization, and body contouring effectively reach the market, supporting the delivery of cutting-edge treatments to patients throughout North America.
Rafael Sierra - Chief Information Officer & Chief Technology Officer
Rafael Sierra, the Chief Information Officer & Chief Technology Officer at Cynosure, architects the company's technological infrastructure and innovation roadmap. Sierra oversees the development and implementation of advanced IT systems and cutting-edge technologies that underpin the creation of energy-based aesthetic and medical treatment systems. This leadership role involves driving digital transformation, ensuring cybersecurity, and fostering technological advancements in areas such as hair removal, skin revitalization, and body contouring. By guiding the technology strategy, Rafael Sierra ensures Cynosure maintains its competitive edge, enabling the delivery of superior treatment solutions to a global network of practitioners and patients.
Sean Flanagan - Chief Legal Officer
Sean Flanagan, the Chief Legal Officer at Cynosure, directs the company's legal affairs and ensures regulatory compliance across all operations. Flanagan oversees the legal framework supporting the development, manufacturing, and distribution of energy-based aesthetic and medical treatment systems, safeguarding the company's interests globally. This executive's responsibilities include managing intellectual property, advising on corporate governance, and mitigating legal risks associated with innovative medical technologies. By providing expert legal counsel, Sean Flanagan ensures Cynosure operates ethically and adheres to all relevant laws and standards, supporting the company's mission to provide advanced treatments to patients worldwide.
Jae Yoo - Chief Operations Officer
Jae Yoo, the Chief Operations Officer at Cynosure, oversees the company's global operational efficiency and manufacturing processes. Yoo directs the execution of strategies that ensure the seamless production and delivery of energy-based aesthetic and medical treatment systems, from initial development to final distribution. This leadership role involves optimizing supply chain management, enhancing production quality, and driving operational improvements across all facilities. By ensuring robust operational frameworks, Jae Yoo supports Cynosure's commitment to providing innovative solutions for hair removal, skin revitalization, and body contouring, enabling practitioners worldwide to offer advanced treatments to their patients.
Explore Leadership Teams in Manufacturing
Terumo is a global medical device company originating from Japan. The company pursues reliable quality and advanced technology to contribute to healthcare across countries and regions worldwide. It focuses on reducing patients’ difficulties both mentally and physically while delivering solutions that help address challenges in medical settings. Terumo remains committed to working alongside healthcare professionals to make meaningful contributions to society, now and into the future.
Company Leadership SU
PL
YK
KT
Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams everywhere. For 70 years, the company's team has driven meaningful innovations in kidney care. Today, patients across more than 100 countries around the world interact with Vantives people, solutions and services over 1 million times each day. As the company builds on the company's legacy, the company is deepening the company's commitment to elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients that is what Vantive aspires to deliver.
Company Leadership
KW
Sisram Medical is a global consumer wellness group specializing in medical aesthetics, offering a wide range of products and services including hair removal, skin rejuvenation, and injectables. With over two decades of experience, the company provides cutting-edge technologies through its brands such as Alma, LMNT, and Copulla, catering to surgical, medical aesthetics, and beauty markets. Sisram Medical's offerings are utilized in leading clinics worldwide, aiming to enhance the quality of life for millions of consumers. The company is committed to innovation, education, and safety in the medical aesthetics industry.
Company Leadership TR
YA
AC
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership
CH
Frequently Asked Questions Regarding Cynosure Top Executives and Leadership Team
Unlock more people and company data
